Malignant glioma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

被引：16

作者：

Stupp, R. ^{[1
]}

Roila, F. ^{[2
]}

机构：

[1] Univ Lausanne, Multidisciplinary Oncol Ctr, Lausanne, Switzerland

[2] Osped S Maria Misericordia, Dept Med Oncol, Perugia, Italy

来源：

ANNALS OF ONCOLOGY | 2008年 / 19卷

关键词：

D O I：

10.1093/annonc/mdn099

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：83 / 85

页数：3

共 24 条

[1]

Afra D, 2002, LANCET, V359, P1011

[2] Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy:: A phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO) [J].

Brandes, AA ;

Tosoni, A ;

Basso, U ;

Reni, M ;

Valduga, F ;

Monfardini, S ;

Amistà, P ;

Nicolardi, L ;

Sotti, G ;

Ermani, M .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (23) :4779-4786

[3] Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402 [J].

Cairncross, Gregory ;

Berkey, Brian ;

Shaw, Edward ;

Jenkins, Robert ;

Scheithauer, Bernd ;

Brachman, David ;

Buckner, Jan ;

Fink, Karen ;

Souhami, Luis ;

Laperierre, Normand ;

Mehta, Minesh ;

Curran, Walter .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) :2707-2714

[4] Medical progress: Brain tumors [J].

DeAngelis, LM .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (02) :114-123

[5] MGMT gene silencing and benefit from temozolomide in glioblastoma [J].

Hegi, ME ;

Diserens, A ;

Gorlia, T ;

Hamou, M ;

de Tribolet, N ;

Weller, M ;

Kros, JM ;

Hainfellner, JA ;

Mason, W ;

Mariani, L ;

Bromberg, JEC ;

Hau, P ;

Mirimanoff, RO ;

Cairncross, JG ;

Janzer, RC ;

Stupp, R .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (10) :997-1003

[6] Current strategies in treatment of oligodendroglioma: Evolution of molecular signatures of response [J].

Jaeckle, KA ;

Ballman, KV ;

Rao, RD ;

Jenkins, RB ;

Buckner, JC .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (08) :1246-1252

[7] Radiotherapy for glioblastoma in the elderly [J].

Keime-Guibert, Florence ;

Chinot, Olivier ;

Taillandier, Luc ;

Cartalat-Carel, Stephanie ;

Frenay, Marc ;

Kantor, Guy ;

Guillamo, Jean-Sebastien ;

Jadaud, Eric ;

Colin, Philippe ;

Bondiau, Pierre-Yves ;

Menei, Philippe ;

Loiseau, Hugues ;

Bernier, Valerie ;

Honnorat, Jerome ;

Barrie, Maryline ;

Mokhtari, Karima ;

Mazeron, Jean-Jacques ;

Bissery, Anne ;

Delattre, Jean-Yves ;

Lacomblez, L. ;

Levy-Soussan, M. ;

Mallet, A. ;

Houssard, C. ;

Delgadillo, D. ;

Poitou, M. ;

Hoang-Xuan, K. ;

Sanson, M. ;

Carpentier, A. F. ;

Laigle-Donadey, F. ;

Taillibert, S. ;

Cornu, P. ;

Omuro, A. ;

Capelle, L. ;

Boch, A. -L. ;

Duffau, H. ;

Simon, J. -M. ;

Medioni, J. ;

Broet, P. ;

Schmitt, A. ;

Garat, E. ;

Mathieu, P. ;

Camille, N. ;

Collin, J. -P. ;

Bailet, B. ;

Ciais, C. ;

Fauchon, F. ;

Lebrun, C. ;

Guesdan, G. ;

Stadelmaier, N. ;

Lombard, I. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (15) :1527-1535

[8] The WHO classification of tumors of the nervous system [J].

Kleihues, P ;

Louis, DN ;

Scheithauer, BW ;

Rorke, LB ;

Reifenberger, G ;

Burger, PC ;

Cavenee, WK .

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2002, 61 (03) :215-225

[9] A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival [J].

Lacroix, M ;

Abi-Said, D ;

Fourney, DR ;

Gokaslan, ZL ;

Shi, WM ;

DeMonte, F ;

Lang, FF ;

McCutcheon, IE ;

Hassenbusch, SJ ;

Holland, E ;

Hess, K ;

Michael, C ;

Miller, D ;

Sawaya, R .

JOURNAL OF NEUROSURGERY, 2001, 95 (02) :190-198

[10] RESPONSE CRITERIA FOR PHASE-II STUDIES OF SUPRATENTORIAL MALIGNANT GLIOMA [J].

MACDONALD, DR ;

CASCINO, TL ;

SCHOLD, SC ;

CAIRNCROSS, JG .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (07) :1277-1280

← 1 2 3 →